Status:
WITHDRAWN
Using Dexmedetomidine Prior to Intubation in Neonates
Lead Sponsor:
Maimonides Medical Center
Conditions:
Effect Neonatal
Eligibility:
All Genders
Up to 120 years
Phase:
PHASE3
Brief Summary
Neonatal intubations are performed routinely in a NICU. Most intubations are still performed without the administration of medications (awake intubations). Some of the reasons are unavailability of a ...
Detailed Description
This is an interventional un-blinded, randomized, prospective pilot study to examine the efficacy of dexmedetomidine in reducing time to intubation, pain/discomfort associated with intubation and main...
Eligibility Criteria
Inclusion
- neonates
- elective intubation
- admitted to the NICU
- Less than 44 weeks corrected gestational age requiring intubation
Exclusion
- babies requiring emergent intubation
- Neonates with birth weight\<1250 grams and \<1 week of postnatal age
- Neonates with major congenital malformations
- Neonates with preexisting hypotension (MAP \< Gest Age)
- Neonates with complex congenital heart disease and heart block
Key Trial Info
Start Date :
March 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05304598
Start Date
March 14 2022
End Date
August 20 2024
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maimonides Medical Center
Brooklyn, New York, United States, 11219